JPH0437831B2 - - Google Patents

Info

Publication number
JPH0437831B2
JPH0437831B2 JP59252786A JP25278684A JPH0437831B2 JP H0437831 B2 JPH0437831 B2 JP H0437831B2 JP 59252786 A JP59252786 A JP 59252786A JP 25278684 A JP25278684 A JP 25278684A JP H0437831 B2 JPH0437831 B2 JP H0437831B2
Authority
JP
Japan
Prior art keywords
group
methyl
amino
dimethoxy
propane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59252786A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60132981A (ja
Inventor
Raifuen Manfuretsudo
Haidaa Yohahimu
Ausuteru Fuorukuharuto
Haueru Noruberuto
Kobingaa Barutaa
Ririi Kurisuchan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of JPS60132981A publication Critical patent/JPS60132981A/ja
Publication of JPH0437831B2 publication Critical patent/JPH0437831B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59252786A 1983-12-03 1984-11-29 新規なインドール誘導体 Granted JPS60132981A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833343801 DE3343801A1 (de) 1983-12-03 1983-12-03 Neue indolderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3343801.3 1983-12-03

Publications (2)

Publication Number Publication Date
JPS60132981A JPS60132981A (ja) 1985-07-16
JPH0437831B2 true JPH0437831B2 (enExample) 1992-06-22

Family

ID=6215987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59252786A Granted JPS60132981A (ja) 1983-12-03 1984-11-29 新規なインドール誘導体

Country Status (20)

Country Link
US (1) US4616011A (enExample)
EP (1) EP0146787B1 (enExample)
JP (1) JPS60132981A (enExample)
KR (1) KR910010134B1 (enExample)
AT (1) ATE36530T1 (enExample)
AU (1) AU577811B2 (enExample)
CA (1) CA1225089A (enExample)
DD (1) DD229699A5 (enExample)
DE (2) DE3343801A1 (enExample)
DK (1) DK571284A (enExample)
ES (2) ES538120A0 (enExample)
FI (1) FI82462C (enExample)
GR (1) GR81106B (enExample)
HU (1) HU193305B (enExample)
IL (1) IL73696A (enExample)
NO (1) NO159596C (enExample)
NZ (1) NZ210403A (enExample)
PH (1) PH23221A (enExample)
PT (1) PT79600B (enExample)
ZA (1) ZA849343B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5175157A (en) * 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3631013A1 (de) * 1986-09-12 1988-03-24 Thomae Gmbh Dr K Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
WO2018094005A1 (en) 2016-11-16 2018-05-24 The General Hospital Corporation Myeloperoxidase imaging agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
DE2639718C2 (de) * 1976-09-03 1987-03-05 Dr. Karl Thomae Gmbh, 7950 Biberach 1-[6,7-Dimethoxy-3,4-dihydro-2H-isochinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-äthyl)-amino]-propan, dessen physiologisch verträgliche Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
DE2860709D1 (en) * 1977-06-28 1981-08-27 Sandoz Ag 1-substituted aminoindolines, process for their production and pharmaceutical compositions containing them
US4462933A (en) * 1979-11-05 1984-07-31 Hoechst-Roussel Pharmaceuticals, Incorporated Process for preparing 4-phenyl-1,3-benzodiazepines
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"

Also Published As

Publication number Publication date
NZ210403A (en) 1988-02-12
EP0146787B1 (de) 1988-08-17
PH23221A (en) 1989-06-06
JPS60132981A (ja) 1985-07-16
GR81106B (en) 1985-04-01
DK571284D0 (da) 1984-11-30
KR910010134B1 (ko) 1991-12-17
EP0146787A2 (de) 1985-07-03
DE3343801A1 (de) 1985-06-13
AU3606884A (en) 1985-06-06
FI82462C (fi) 1991-03-11
ES542723A0 (es) 1985-12-16
ES8603471A1 (es) 1985-12-16
DE3473451D1 (en) 1988-09-22
EP0146787A3 (en) 1985-11-21
PT79600A (de) 1985-01-01
FI844709A0 (fi) 1984-11-30
NO844780L (no) 1985-06-04
ATE36530T1 (de) 1988-09-15
ES8601974A1 (es) 1985-11-01
NO159596B (no) 1988-10-10
NO159596C (no) 1989-01-18
FI82462B (fi) 1990-11-30
CA1225089A (en) 1987-08-04
US4616011A (en) 1986-10-07
IL73696A0 (en) 1985-02-28
ES538120A0 (es) 1985-11-01
KR850004753A (ko) 1985-07-27
PT79600B (de) 1986-12-12
DK571284A (da) 1985-06-04
FI844709L (fi) 1985-06-04
HU193305B (en) 1987-09-28
ZA849343B (en) 1986-08-27
HUT37143A (en) 1985-11-28
AU577811B2 (en) 1988-10-06
DD229699A5 (de) 1985-11-13
IL73696A (en) 1987-10-30

Similar Documents

Publication Publication Date Title
US4584293A (en) Aminotetralin derivatives
BE1006343A5 (fr) Derives de l'indole.
JP2614981B2 (ja) インドール、インダゾール及びベンズイソオキサゾール化合物、それらの製法およびそれらを含有する製薬組成物
JPH0623197B2 (ja) インドール誘導体
JP2005535655A (ja) ムスカリン性受容体拮抗剤としてのアザビシクロ誘導体
SK93198A3 (en) Quinoline-2-(1h)-one derivative, preparation method thereof and pharmaceutical composition containing the same
JPH0437831B2 (enExample)
JPS6379876A (ja) 新規なナフチル誘導体、その製造法およびそれらの化合物を含有する医薬組成物
JPS6365663B2 (enExample)
KR100382998B1 (ko) 6-메톡시-1h-벤조트리아졸-5-카르복사미드유도체,그제조방법및그것을함유하는의약조성물
EP0402232A1 (fr) Dérivés de pyridobenzoindole, leur préparation et les compositions qui les contiennent
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
US7683092B2 (en) Crystalline forms of antidiabetic compounds
JPS6345667B2 (enExample)
JPH0441144B2 (enExample)
JP3222051B2 (ja) ６−メトキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体
JPH0521910B2 (enExample)
JPH0344371A (ja) 新規１，４―ジヒドロピリジン誘導体
JPH09301972A (ja) Ｎ−（１−置換−アザシクロアルカン−３−イル）カルボキサミド誘導体及びそれを含有する医薬組成物
FI88154C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h-bens/e/indoler
BE898221A (fr) Dérivés d'azepino (1,2-a) pyrimidine bronchodilatateurs, leurs sels d'addition d'acides et compositions pharmaceutiques qui les contiennent.
JPS6247186B2 (enExample)
BE869191A (fr) Nouvelles imidazo-isoquinoleine-diones, procedes pour leur preparation et leur utilisation en tant que medicaments
JP2002522538A (ja) Ｎ−置換アザビシクロヘプタン誘導体、ならびにその製造および使用
JPH08225571A (ja) ６−アルコキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体及びその中間体並びに該化合物を含有する医薬組成物